Celon Pharma
CLN.WA
#7203
Rank
C$0.51 B
Marketcap
$9.57
Share price
1.96%
Change (1 day)
84.98%
Change (1 year)

EPS for Celon Pharma (CLN.WA)

EPS in 2024 (TTM): -$0.15

According to Celon Pharma's latest financial reports the company's current EPS (TTM) is -$0.15. In 2023 the company made an earnings per share (EPS) of -$0.19 an increase over its 2022 EPS that were of -$0.24.

EPS history for Celon Pharma from 2015 to 2024

Annual EPS

Year EPS Change
2024 (TTM)-$0.15-24.02%
2023-$0.19-20.64%
2022-$0.24186.32%
2021-$0.085391047.74%
2020-$0.007440-107.56%
2019$0.09847-59.53%
2018$0.247.36%
2017$0.23-18.58%
2016$0.28-5.31%
2015$0.29